Skip to main content
Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Important information

The contents of this webpage are in French only.

Document relatif à la demande d’accès 7212-2024-05230

Document administratif
Updated on

 09 October 2024

La demande d’accès concerne le nombre de services pharmaceutiques associés au médicament Ozempic, par mois, pour la période du 1er janvier 2023 au 15 septembre 2024.